TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer

• There is a lack of prospective level I evidence for the use of PBT for most adult cancers including oropharyngeal squamous cell carcinoma (OPSCC). • TORPEdO is the UK’s first PBT clinical trial and aims to determine the benefits of PBT for OPSCC. • Training and support has been provided before and...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, David J., Cruickshank, Clare, Baines, Helen, Banner, Russell, Beasley, Matthew, Betts, Guy, Bulbeck, Helen, Charlwood, Frances, Christian, Judith, Clarke, Matthew, Donnelly, Olly, Foran, Bernadette, Gillies, Callum, Griffin, Clare, Homer, Jarrod J., Langendijk, Johannes A., Lee, Lip Wai, Lester, James, Lowe, Matthew, McPartlin, Andrew, Miles, Elizabeth, Nutting, Christopher, Palaniappan, Nachi, Prestwich, Robin, Price, James M., Roberts, Clare, Roe, Justin, Shanmugasundaram, Ramkumar, Simões, Rita, Thompson, Anna, West, Catharine, Wilson, Lorna, Wolstenholme, Jane, Hall, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702982/
https://www.ncbi.nlm.nih.gov/pubmed/36452431
http://dx.doi.org/10.1016/j.ctro.2022.11.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702982/
https://www.ncbi.nlm.nih.gov/pubmed/36452431
http://dx.doi.org/10.1016/j.ctro.2022.11.010

Ejemplares similares